Recombinant CD38 (Isatuximab Biosimilar) antibody

Catalog No. ABIN7795129

The Humanized Monoclonal anti-CD38 (Isatuximab Biosimilar) antibody (ABIN7795129) specifically detects CD38 (Isatuximab Biosimilar) in FACS and in vivo. The antibody is reactive with Human samples.

Quick Overview for Recombinant CD38 (Isatuximab Biosimilar) antibody (ABIN7795129)

Target: CD38 (Isatuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CD38 (Isatuximab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade: Research Grade

Product Details anti-CD38 (Isatuximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Isatuximab Biosimilar, CD38 Monoclonal Antibody

Characteristics: Isatuximab Biosimilar uses the same protein sequences as the therapeutic antibody isatuximab. Isatuximab is a humanized, IgG1-derived monoclonal antibody (mAb) produced from a Chinese hamster ovary (CHO) cell line. Structurally, isatuximab is comprised of two identical immunoglobulin kappa light chains and two identical immunoglobulin gamma heavy chains. It is a cytolytic antibody targeted against CD38, a glycoprotein found on the surface of some immune cells that is highly expressed by malignant plasma cells in multiple myeloma. Along with daratumumab, another anti-CD38 monoclonal antibody, isatuximab constitutes a novel treatment modality for patients with difficult-to-treat multiple myeloma.

Purification: Protein A or G affinity column

Purity: >95 % by reducing SDS-PAGE

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method

Immunogen: Human CD38

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: > 3 mg/mL

Storage: 4 °C,-20 °C

Storage Comment: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Target Details for CD38 (Isatuximab Biosimilar)

Target: CD38 (Isatuximab Biosimilar)

Alternative Name: Isatuximab Biosimilar

Target Type: Biosimilar